title: Serum interleukin-6 levels as an early marker of therapeutic response to UVB radiation and topical steroids in psoriatic patients.
authors.forename: C
authors.initials: C
authors.lastname: Bonifati
authors.forename: M
authors.initials: M
authors.lastname: Solmone
authors.forename: E
authors.initials: E
authors.lastname: Trento
authors.forename: M
authors.initials: M
authors.lastname: Pietravalle
authors.forename: M
authors.initials: M
authors.lastname: Fazio
authors.forename: F
authors.initials: F
authors.lastname: Ameglio
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001623:Betamethasone / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D008875:Middle Aged; D011565:Psoriasis / Q000628:therapy*; D012459:Salicylates / Q000627:therapeutic use; D020156:Salicylic Acid; D012720:Severity of Illness Index; D014467:Ultraviolet Therapy
chemical_list: D015415:Biomarkers; D015850:Interleukin-6; D012459:Salicylates; D001623:Betamethasone; D020156:Salicylic Acid